Patterns of Outpatient and Acute Care Use Among Patients with SLE on Long-Term Moderate to High Dose Glucocorticoid Medication: A 1 Year Retrospective Analysis

被引:0
|
作者
Sullivan, James [1 ]
Littlejohn, Emily [2 ]
机构
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1452
引用
收藏
页码:2865 / 2868
页数:4
相关论文
共 50 条
  • [41] Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study
    Richard A. Deyo
    Sara E. Hallvik
    Christi Hildebran
    Miguel Marino
    Eve Dexter
    Jessica M. Irvine
    Nicole O’Kane
    Joshua Van Otterloo
    Dagan A. Wright
    Gillian Leichtling
    Lisa M. Millet
    Journal of General Internal Medicine, 2017, 32 : 21 - 27
  • [42] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Chronic Migraine Who Have Failed At least One Prior Preventive Migraine Medication: Results of a 1-Year Study
    McAllister, P.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 119 - 119
  • [43] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine Who Have Failed At least One Prior Preventive Migraine Medication: Results of a 1-Year Study
    Brandes, J.
    Smith, T. R.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 119 - 120
  • [44] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with episodic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
    Brandes, Jan L.
    Smith, Timothy R.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Carr, Karen
    CEPHALALGIA, 2019, 39 : 233 - 233
  • [45] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with chronic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
    McAllister, Peter
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Elms, Shawn
    CEPHALALGIA, 2019, 39 : 231 - 232
  • [46] Association between changes in the use of psychotropic drugs and behavioural and psychological symptoms of dementia over 1 year among long-term care facility residents
    Ozaki, Takashi
    Katsumata, Yuriko
    Arai, Asuna
    PSYCHOGERIATRICS, 2019, 19 (02) : 126 - 134
  • [47] Healthcare Resource Utilization Among Patients with Focal Seizure Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
    Mehta, Darshan
    Shah, Drishti
    Desai, Vibha
    DeKoven, Mitch
    DePue, Ronald
    Williams, G. Rhys
    Saffel, Dana
    NEUROLOGY AND THERAPY, 2021, 10 (02) : 673 - 691
  • [48] Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
    Darshan Mehta
    Drishti Shah
    Vibha Desai
    Mitch DeKoven
    Ronald DePue
    G. Rhys Williams
    Dana Saffel
    Neurology and Therapy, 2021, 10 : 673 - 691
  • [49] One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins
    Campitelli, Michael A.
    Maxwell, Colleen J.
    Maclagan, Laura C.
    Ko, Dennis T.
    Bell, Chaim M.
    Jeffs, Lianne
    Morris, Andrew M.
    Lapane, Kate L.
    Daneman, Nick
    Bronskill, Susan E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (02) : E32 - E39
  • [50] Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services
    Hendrix, Ivanka
    Page, Amy T.
    Korhonen, Maarit J.
    Bell, J. Simon
    Tan, Edwin C. K.
    Visvanathan, Renuka
    Cooper, Tina
    Robson, Leonie
    Sluggett, Janet K.
    DRUGS-REAL WORLD OUTCOMES, 2019, 6 (03) : 105 - 113